Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parmar, J S
Right arrow Articles by Bilton, D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parmar, J S
Right arrow Articles by Bilton, D
Thorax 2002;57:749-750
© 2002 Thorax


CASE REPORT

Profound adrenal suppression secondary to treatment with low dose inhaled steroids and itraconazole in allergic bronchopulmonary aspergillosis in cystic fibrosis

J S Parmar, T Howell, J Kelly, D Bilton

Adult CF Unit Papworth Hospital, Papworth NHS Trust, Papworth Everard, Cambridge CB3 8RE, UK

Correspondence to:
Correspondence to:
Dr J S Parmar, Adult CF Unit, Papworth NHS Trust, Papworth Everard, Cambridge CB3 8RE, UK;
jsp35{at}hermes.cam.ac.uk


ABSTRACT
The case history is presented of a patient with cystic fibrosis in whom the treatment of allergic bronchopulmonary aspergillosis with itraconazole produced an initial response but was complicated by profound adrenal shutdown and impairment of inhaled steroid clearance resulting in paradoxical Cushing’s syndrome. The authors conclude that, while it is laudable to attempt to reduce the steroid burden in any patient, it is imperative that due vigilance is exercised when using a combination of agents which interact. If such a combination therapy is embarked upon, regular assessment of the pituitary adrenal axis is advisable.


Keywords: cystic fibrosis; allergic bronchopulmonary aspergillosis; adrenal suppression; itraconazole




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
I. M. Balfour-Lynn, B. Lees, P. Hall, G. Phillips, M. Khan, M. Flather, J. S. Elborn, and on behalf of the CF WISE (Withdrawal of Inhaled St
Multicenter Randomized Controlled Trial of Withdrawal of Inhaled Corticosteroids in Cystic Fibrosis
Am. J. Respir. Crit. Care Med., June 15, 2006; 173(12): 1356 - 1362.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
D R Woods, C S Arun, P A Corris, and P Perros
Cushing's syndrome without excess cortisol.
BMJ, February 25, 2006; 332(7539): 469 - 470.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2002 BMJ Publishing Group Ltd & British Thoracic Society